Search research articles
Contact Us
Filters
Showing results (271-280 of 285) with videos related to
Page
of 29
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 1998
Low intercellular adhesion molecule 1 and high 5T4 expression on tumor cells correlate with reduced disease-free survival in colorectal carcinoma patients
W M Mulder, P L Stern, M J Stukart, et al.
Journal of the National Cancer Institute
|
May 7, 1997
Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia
T D de Gruijl, H J Bontkes, J M Walboomers, et al.
Cancer Research
|
May 1, 1998
Differential T helper cell responses to human papillomavirus type 16 E7 related to viral clearance or persistence in patients with cervical neoplasia: a longitudinal study
T D de Gruijl, H J Bontkes, J M Walboomers, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 17, 1999
Differences in cytokine mRNA profiles between premalignant and malignant lesions of the uterine cervix
T D de Gruijl, H J Bontkes, A J van den Muysenberg, et al.
The Journal of General Virology
|
March 12, 1999
Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome
T D de Gruijl, H J Bontkes, J M Walboomers, et al.
International Journal of Cancer
|
December 11, 1996
Analysis of IgG reactivity against Human Papillomavirus type-16 E7 in patients with cervical intraepithelial neoplasia indicates an association with clearance of viral infection: results of a prospective study
T D de Gruijl, H J Bontkes, J M Walboomers, et al.
British Journal of Cancer
|
April 16, 2002
A phase II study of active specific immunotherapy and 5-FU/Leucovorin as adjuvant therapy for stage III colon carcinoma
A Baars, A M E Claessen, J Wagstaff, et al.
Clinical Immunology (Orlando, Fla.)
|
July 24, 2001
Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage
H J van der Vliet, B M von Blomberg, N Nishi, et al.
Cancer Immunology, Immunotherapy : CII
|
July 22, 2005
Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients
J B A G Haanen, A Baars, R Gomez, et al.
International Journal of Cancer
|
August 30, 2000
Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia
H J Bontkes, T D de Gruijl, A J van den Muysenberg, et al.
Page
of 29
Search research articles
Search
Showing results (271-280 of 285) with videos related to
Sort By:
Page
of 29
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 1998
Low intercellular adhesion molecule 1 and high 5T4 expression on tumor cells correlate with reduced disease-free survival in colorectal carcinoma patients
W M Mulder, P L Stern, M J Stukart, et al.
Journal of the National Cancer Institute
|
May 7, 1997
Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia
T D de Gruijl, H J Bontkes, J M Walboomers, et al.
Cancer Research
|
May 1, 1998
Differential T helper cell responses to human papillomavirus type 16 E7 related to viral clearance or persistence in patients with cervical neoplasia: a longitudinal study
T D de Gruijl, H J Bontkes, J M Walboomers, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 17, 1999
Differences in cytokine mRNA profiles between premalignant and malignant lesions of the uterine cervix
T D de Gruijl, H J Bontkes, A J van den Muysenberg, et al.
The Journal of General Virology
|
March 12, 1999
Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome
T D de Gruijl, H J Bontkes, J M Walboomers, et al.
International Journal of Cancer
|
December 11, 1996
Analysis of IgG reactivity against Human Papillomavirus type-16 E7 in patients with cervical intraepithelial neoplasia indicates an association with clearance of viral infection: results of a prospective study
T D de Gruijl, H J Bontkes, J M Walboomers, et al.
British Journal of Cancer
|
April 16, 2002
A phase II study of active specific immunotherapy and 5-FU/Leucovorin as adjuvant therapy for stage III colon carcinoma
A Baars, A M E Claessen, J Wagstaff, et al.
Clinical Immunology (Orlando, Fla.)
|
July 24, 2001
Circulating V(alpha24+) Vbeta11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage
H J van der Vliet, B M von Blomberg, N Nishi, et al.
Cancer Immunology, Immunotherapy : CII
|
July 22, 2005
Melanoma-specific tumor-infiltrating lymphocytes but not circulating melanoma-specific T cells may predict survival in resected advanced-stage melanoma patients
J B A G Haanen, A Baars, R Gomez, et al.
International Journal of Cancer
|
August 30, 2000
Human papillomavirus type 16 E6/E7-specific cytotoxic T lymphocytes in women with cervical neoplasia
H J Bontkes, T D de Gruijl, A J van den Muysenberg, et al.
Page
of 29